Conditional approval for Spikevax vaccine for 12-year-olds and above
The Spikevax brand COVID-19 vaccine produced by Rovi Pharma Industrial Services in Spain has been given conditional approval for use in Malaysia by 12-year-olds and above.
Thu Aug 04 2022